BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.49
−1.70%Leverage
- Debt / equity
- 0.58x
- Net debt / equity
- 0.24x
- Debt / assets
- 0.24x
- Debt / EBITDA
- -35.33x
- Net debt / EBITDA
- -14.74x
Liquidity & coverage
- Current ratio
- 1.20x
- Quick ratio
- 1.04x
- Cash ratio
- 0.96x
- Interest coverage
- -8.04x
- EBITDA / interest
- -0.17x
- Working capital
- $2.7M
Cash & dividend
- FCF / debt
- -1.03x
- Cash flow / debt
- -1.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026